Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
Business Wire•12/08/2026•08:00 ET
0
Whiz Insights
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.
Get started
Create a free account to read the full story.